Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma. The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Aldeyra Therapeutics Inc..
Aldeyra Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Aldeyra Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Aldeyra Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Aldeyra Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Aldeyra Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Aldeyra Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Aldeyra Therapeutics Inc.- Key Facts
2.2 Aldeyra Therapeutics Inc.- Geographic Locations
2.3 Aldeyra Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Aldeyra Therapeutics Inc.- Business Divisions
2.5 Aldeyra Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Aldeyra Therapeutics Inc. Strategic Analysis Review
3.1 Aldeyra Therapeutics Inc.- Key Strategies
3.2 Aldeyra Therapeutics Inc.- Company Outlook Statement
3.3 Aldeyra Therapeutics Inc.- SWOT Analysis
3.3.1 Aldeyra Therapeutics Inc.- Key Strengths
3.3.2 Aldeyra Therapeutics Inc.- Key Weaknesses
3.3.3 Aldeyra Therapeutics Inc.- Potential Opportunities
3.3.4 Aldeyra Therapeutics Inc.- Potential Threats
3.4 Aldeyra Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Aldeyra Therapeutics Inc.- Business Overview
4.2 Aldeyra Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Aldeyra Therapeutics Inc.- Key Products
5.2 Aldeyra Therapeutics Inc.- Key Service Areas
5.3 Aldeyra Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Aldeyra Therapeutics Inc.- Company History
6.2 Aldeyra Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Aldeyra Therapeutics Inc.- Income Statements
7.2 Aldeyra Therapeutics Inc.- Balance Sheet
7.3 Aldeyra Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Aldeyra Therapeutics Inc.- Direct Competitors
8.2 Aldeyra Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Aldeyra Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Aldeyra Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
